vs
Side-by-side financial comparison of RAPID MICRO BIOSYSTEMS, INC. (RPID) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.3M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.6M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | $-12.5M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | $-11.3M | — | ||
| Q4 24 | $-9.7M | — | ||
| Q3 24 | $-11.3M | — | ||
| Q2 24 | $-12.6M | — | ||
| Q1 24 | $-13.3M | — |
| Q4 25 | -108.2% | — | ||
| Q3 25 | -145.1% | — | ||
| Q2 25 | -167.3% | — | ||
| Q1 25 | -161.8% | — | ||
| Q4 24 | -124.5% | — | ||
| Q3 24 | -158.3% | — | ||
| Q2 24 | -202.1% | — | ||
| Q1 24 | -254.4% | — |
| Q4 25 | -110.8% | — | ||
| Q3 25 | -146.8% | — | ||
| Q2 25 | -163.3% | — | ||
| Q1 25 | -156.3% | — | ||
| Q4 24 | -117.6% | — | ||
| Q3 24 | -148.9% | — | ||
| Q2 24 | -190.1% | — | ||
| Q1 24 | -237.4% | — |
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $-0.26 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.26 | — | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.26 | — | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.31 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
